Quantification of pramipexole in human plasma by liquid chromatography tandem mass spectrometry using tamsulosin as internal standard

被引:24
作者
Nirogi, Ramakrishna V. S. [1 ]
Kandikere, Vishwottam [1 ]
Shrivastava, Wishu [1 ]
Mudigonda, Koteshwara [1 ]
Maurya, Santosh [1 ]
Ajjala, Devender [1 ]
机构
[1] Suven Life Sci Ltd, Hyderabad 500034, Andhra Pradesh, India
关键词
pramipexole; liquid chromatography-tandem mass spectrometry; human plasma; pharmacokinetic study;
D O I
10.1002/bmc.864
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A high-performance liquid chromatography/electrospray ionization tandem mass spectrometry method was developed and validated for the quantification of pramipexole in human plasma. Following liquid-liquid extraction, the analytes were separated using an isocratic mobile phase on a reverse-phase column and analyzed by MS/MS in the multiple reaction monitoring mode using the respective [M + H](+) ions, m/z 212/152 for pramipexole and m/z 409/228 for the IS. The method exhibited a linear dynamic range of 200-8000 pg/mL for pramipexole in human plasma. The lower limit of quantification was 200 pg/mL with a relative standard deviation of less than 8%. Acceptable precision and accuracy were obtained for concentrations over the standard curve range. A run time of 3.5 min for each sample made it possible to analyze more than 200 human plasma samples per day. The validated method has been successfully used to analyze human plasma samples for application in pharmacokinetic, bioavailability or bioequivalence studies. Copyright (c) 2007 John Wiley & Sons, Ltd.
引用
收藏
页码:1151 / 1158
页数:8
相关论文
共 10 条
[1]   Pramipexole - a new dopamine agonist for the treatment of Parkinson's disease [J].
Bennett, JP ;
Piercey, MF .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 163 (01) :25-31
[2]  
Lau YY, 1996, J CHROMATOGR B, V683, P209
[3]  
Lau YY, 1996, J CHROMATOGR B, V683, P217
[4]   Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS [J].
Matuszewski, BK ;
Constanzer, ML ;
Chavez-Eng, CM .
ANALYTICAL CHEMISTRY, 2003, 75 (13) :3019-3030
[5]   BIOCHEMICAL AND PHARMACOLOGICAL STUDIES ON PRAMIPEXOLE, A POTENT AND SELECTIVE DOPAMINE-D2 RECEPTOR AGONIST [J].
MIERAU, J ;
SCHINGNITZ, G .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 215 (2-3) :161-170
[6]   PRAMIPEXOLE BINDING AND ACTIVATION OF CLONED AND EXPRESSED DOPAMINE D-2, D-3 AND D-4 RECEPTORS [J].
MIERAU, J ;
SCHNEIDER, FJ ;
ENSINGER, HA ;
CHIO, CL ;
LAJINESS, ME ;
HUFF, RM .
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1995, 290 (01) :29-36
[7]   Inhibition of dopamine neuron firing by pramipexole, a dopamine D-3 receptor-preferring agonist, comparison to other dopamine receptor agonists [J].
Piercey, MF ;
Hoffmann, WE ;
Smith, MW ;
Hyslop, DK .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 312 (01) :35-44
[8]   A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease [J].
Relja, Maja ;
Klepac, Natasa .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) :251-254
[9]  
SHAH VP, 1991, EUR J DRUG METAB PH, V16, P249
[10]   Steady-state pharmacokinetic properties of pramipexole in healthy volunteers [J].
Wright, CE ;
Sisson, TL ;
Ichhpurani, AK ;
Peters, GR .
JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 37 (06) :520-525